Francesca Aleotti

Dr. Francesca Aleotti

IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2022 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
EMElisa Montaldo
Elisa Montaldo
ELEleonora Lusito
Eleonora Lusito
VBValentina Bianchessi
Valentina Bianchessi
NCNicoletta Caronni
Nicoletta Caronni
SSSerena Scala
Serena Scala
RORenato Ostuni
Renato Ostuni

30 September 2022 in Annals of Surgery
Verified
Journal Article
Open access
Gianpaolo BalzanoGianpaolo Balzano
Gianpaolo Balzano
AZAlessandro Zerbi
Alessandro Zerbi
FAFrancesca Aleotti
Francesca Aleotti
GCGiovanni Capretti
Giovanni Capretti
RMRaffella Bsc Melzi
Raffella Bsc Melzi
LPLorenzo Piemonti
Lorenzo Piemonti
Objective: To compare pancreaticoduodenectomy (PD) and total pancreatectomy (TP) with islet autotransplantation (IAT) in patients at high risk of postoperative pancreatic fistula (POPF). Background: Criteria to predict the risk of POPF occurrence after PD are available. However, even when a high risk of POPF is predicted, TP is not currently accepted as an alternative to PD, because of its severe consequences on glycaemic control. Combining IAT with TP may mitigate such consequences. Methods: Randomized, open-label, controlled, bicentric trial (NCT01346098). Candidates for PD at high-risk pancreatic anastomosis (ie, soft pancreas and duct diameter ≤3 mm) were randomly assigned (1:1) to undergo either PD or TP-IAT. The primary endpoint was the incidence of complications within 90 days after surgery. Results: Between 2010 and 2019, 61 patients were assigned to PD (n=31) or TP-IAT (n=30). In the intention-to-treat analysis, morbidity rate was 90·3% after PD and 60% after TP-IAT (P=0.008). According to complications’ severity, PD was associated with an increased risk of grade ≥2 [odds ratio (OR)=7.64 (95% CI: 1.35–43.3), P=0.022], while the OR for grade ≥3 complications was 2.82 (95% CI: 0.86–9.24, P=0.086). After TP-IAT, the postoperative stay was shorter [median: 10.5 vs 16.0 days; P<0.001). No differences were observed in disease-free survival, site of recurrence, disease-specific survival, and overall survival. TP-IAT was associated with a higher risk of diabetes [hazard ratio=9.1 (95% CI: 3.76–21.9), P<0.0001], but most patients maintained good metabolic control and showed sustained C-peptide production over time. Conclusions: TP-IAT may become the standard treatment in candidates for PD, when a high risk of POPF is predicted.

13 February 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
GGGiovanni Guarneri
Giovanni Guarneri
NPNicolò Pecorelli
Nicolò Pecorelli
ABAndrea Bettinelli
Andrea Bettinelli
ACAntonino Campisi
Antonino Campisi
DPDiego Palumbo
Diego Palumbo
MFMassimo Falconi
Massimo Falconi

30 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
DPDiego Palumbo
Diego Palumbo
MMMartina Mori
Martina Mori
Francesco PratoFrancesco Prato
Francesco Prato
SCStefano Crippa
Stefano Crippa
GBGiulio Belfiori
Giulio Belfiori
Francesco De CobelliFrancesco De Cobelli
Francesco De Cobelli
Despite careful selection, the recurrence rate after upfront surgery for pancreatic adenocarcinoma can be very high. We aimed to construct and validate a model for the prediction of early distant recurrence (<12 months from index surgery) after upfront pancreaticoduodenectomy. After exclusions, 147 patients were retrospectively enrolled. Preoperative clinical and radiological (CT-based) data were systematically evaluated; moreover, 182 radiomics features (RFs) were extracted. Most significant RFs were selected using minimum redundancy, robustness against delineation uncertainty and an original machine learning bootstrap-based method. Patients were split into training (n = 94) and validation cohort (n = 53). Multivariable Cox regression analysis was first applied on the training cohort; the resulting prognostic index was then tested in the validation cohort. Clinical (serum level of CA19.9), radiological (necrosis), and radiomic (SurfAreaToVolumeRatio) features were significantly associated with the early resurge of distant recurrence. The model combining these three variables performed well in the training cohort (p = 0.0015, HR = 3.58, 95%CI = 1.98–6.71) and was then confirmed in the validation cohort (p = 0.0178, HR = 5.06, 95%CI = 1.75–14.58). The comparison of survival curves between low and high-risk patients showed a p-value <0.0001. Our model may help to better define resectability status, thus providing an actual aid for pancreatic adenocarcinoma patients’ management (upfront surgery vs. neoadjuvant chemotherapy). Independent validations are warranted.

3 June 2022 in Surgery
Verified
Journal Article
Closed access
FAFrancesca Aleotti
Francesca Aleotti
SCStefano Crippa
Stefano Crippa
GBGiulio Belfiori
Giulio Belfiori
DTDomenico Tamburrino
Domenico Tamburrino
SPStefano Partelli
Stefano Partelli
MFMassimo Falconi
Massimo Falconi

25 November 2023 in Digestive and Liver Disease
Verified
Journal Article
Closed access
GRGemma Rossi
Gemma Rossi
MPMaria Chiara Petrone
Maria Chiara Petrone
MTMatteo Tacelli
Matteo Tacelli
PZPiera Zaccari
Piera Zaccari
SCStefano Crippa
Stefano Crippa
PAPaolo Giorgio Arcidiacono
Paolo Giorgio Arcidiacono